NASDAQ$NUTX
Nutex Health Inc · Q2 2024 earnings
Q2 2024 earnings ·
Briefing
NUTX Q2 2024 — $300K revenue, 27.00 EPS
Some or all of such beliefs, expectations, and assumptions may not materialize or may vary significantly from actual results. Nutex Health Inc reported Q2 2024 results. Diluted EPS came in at $27.00. Net income of $400K. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $300K.
- Diluted EPS: $27.00.
- Net income: $400K.
Headline financials
Revenue & EPS history
Nutex Health Inc · Revenue · Quarterly
$76.1M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q2 2024
+1.9%
Avg return
Earnings day
+17.2%
Avg return
5 days after
+21.1%
Avg return
30 days after
62%
8 / 13 earnings
Positive
+22.4%
Q1 2022
Best reaction
-14.3%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +6.4% | +8.0% | +14.4% | |
| Q4 2025 | -14.3% | -14.1% | -4.2% | |
| Q3 2025 | +0.0% | +32.9% | +64.1% | |
| Q1 2025 | +1.0% | +40.2% | +0.2% | |
| Q3 2024 | +6.3% | +38.2% | +39.3% | |
| Q2 2024 | +0.9% | +62.7% | +173.1% | |
| Q1 2024 | +6.2% | +14.8% | +0.7% | |
| Q3 2023 | +0.0% | -6.0% | -22.8% | |
| Q2 2023 | +3.6% | +0.9% | -20.1% | |
| Q1 2023 | +8.9% | +10.3% | -17.8% | |
| Q3 2022 | -9.2% | +1.7% | +59.7% | |
| Q2 2022 | -8.2% | -27.9% | -53.8% | |
| Q1 2022 | +22.4% | +61.8% | +41.2% | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro